(a) General. (1) Tolerances are established for the combined residues of pinoxaden (8-(2,6-diethyl-4-methylphenyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5] oxadiazepin-9-yl 2,2-dimethylpropanoate), and its metabolites 8-(2,6-diethyl-4-methyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepine-7,9-dione (M2), and free and conjugated forms of 8-(2,6-diethyl-4-hydroxymethyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5] oxadiazepine-7,9-dione (M4), and 4-(7,9-dioxo-hexahydro-pyrazolo[1,2-d] [1,4,5]oxadiazepin-8-yl)-3,5-diethyl-benzoic acid (M6), calculated as pinoxaden, in/on the following commodities: ------------------------------------------------------------------------
Parts per
Commodity million------------------------------------------------------------------------Barley, bran................................................ 1.6Barley, grain............................................... 0.9Barley, hay................................................. 1.5Barley, straw............................................... 1.0Egg......................................................... 0.06Poultry, fat................................................ 0.06Poultry, meat............................................... 0.06Poultry, meat byproducts.................................... 0.06Wheat, bran................................................. 3.0Wheat, forage............................................... 3.5Wheat, grain................................................ 1.3Wheat, hay.................................................. 2.0Wheat, straw................................................ 1.5------------------------------------------------------------------------
(2) For the combined residues of pinoxaden, 8-(2,6-diethyl-4-methylphenyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5] oxadiazepin-9-yl 2,2-dimethylpropanoate), and its metabolites M2, 8-(2,6-diethyl-4-methyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5]oxadiazepine-7,9-dione, and free and conjugated forms of M4, 8-(2,6-diethyl-4-hydroxymethyl-phenyl)-tetrahydro-pyrazolo[1,2-d][1,4,5] oxadiazepine-7,9-dione, calculated as pinoxaden, in/on the following commodities: ------------------------------------------------------------------------
Parts per
Commodity million------------------------------------------------------------------------Cattle, fat................................................. 0.04Cattle, meat................................................ 0.04Cattle, meat byproducts..................................... 0.04Milk........................................................ 0.02------------------------------------------------------------------------
(b) Section 18 emergency exemptions. [Reserved]
(c) Tolerances with regional registrations. [Reserved]
(d) Indirect or inadvertent residues. [Reserved] [70 FR 43322, July 27, 2005]